KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Shares Issued (2016 - 2024)

Evolent Health (EVH) has 10 years of Shares Issued data on record, last reported at -$1000.0 in Q4 2024.

  • For Q4 2024, Shares Issued fell 100.03% year-over-year to -$1000.0; the TTM value through Sep 2025 reached -$1000.0, down 100.01%, while the annual FY2024 figure was $3.5 million, 72.35% down from the prior year.
  • Shares Issued reached -$1000.0 in Q4 2024 per EVH's latest filing, down from $2.3 million in the prior quarter.
  • Across five years, Shares Issued topped out at $6.5 million in Q1 2021 and bottomed at -$1000.0 in Q4 2024.
  • Average Shares Issued over 5 years is $1.9 million, with a median of $1.6 million recorded in 2023.
  • Peak YoY movement for Shares Issued: surged 7659.52% in 2021, then plummeted 100.03% in 2024.
  • A 5-year view of Shares Issued shows it stood at $603000.0 in 2020, then soared by 185.74% to $1.7 million in 2021, then crashed by 31.98% to $1.2 million in 2022, then soared by 184.64% to $3.3 million in 2023, then plummeted by 100.03% to -$1000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Shares Issued were -$1000.0 in Q4 2024, $2.3 million in Q3 2024, and $61000.0 in Q2 2024.